Michael Braden Leonard

Affiliations

  • at An2 Therapeutics Inc. (ANTX), 2025-06-16
  • at Adverum Biotechnologies Inc. (ADVM), 2025-04-28
  • at Onkure Therapeutics Inc. (OKUR), 2024-10-09
  • at Talis Biomedical Corp (TLIS), 2024-09-09
  • at Aclaris Therapeutics Inc. (ACRS), 2024-08-05
  • at Tectonic Therapeutic Inc. (TECX), 2024-06-25
  • at Cyteir Therapeutics Inc. (CYT), 2024-03-25
  • Large Shareholder at Imara Inc. (IMRA), 2023-01-06
  • Large Shareholder at Retractable Technologies Inc (RVP), 2022-12-29
  • Large Shareholder at Metacrine Inc. (MTCR), 2022-12-21
  • Large Shareholder at Astrotech Corp (ASTC), 2022-12-02
  • Large Shareholder at Satsuma Pharmaceuticals Inc. (STSA), 2022-11-23
  • Large Shareholder at Gemini Therapeutics Inc. (GMTX), 2022-10-27
  • Large Shareholder at Orchids Paper Products Co (TISUQ), 2019-04-10
  • Other at Build A Bear Workshop Inc (BBW), 2017-10-02
  • Large Shareholder at Prophase Labs Inc. (PRPH), 2017-10-02
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ADVM $5.19 16,593 $86,089.46 141,800 2025-03-27 Filing
ADVM $5.04 20,407 $102,841.08 125,207 2025-03-26 Filing
ADVM $5.19 16,593 $86,089.46 141,800 2025-03-27 Filing
ADVM $5.04 20,407 $102,841.08 125,207 2025-03-26 Filing
ADVM $2.98 50,000 $148,950.00 191,800 2025-04-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ANTX $1.09 200,000 $218,000.00 3,017,432 2025-05-28 Filing
ANTX $1.03 7,000 $7,226.80 3,217,432 2025-05-30 Filing
ANTX $1.01 425,000 $429,250.00 3,224,432 2025-05-30 Filing
ANTX $1.16 100,000 $116,000.00 3,649,432 2025-05-28 Filing
ANTX $1.16 2,000,000 $2,320,000.00 3,749,432 2025-05-28 Filing